ABT vs. ZBH: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABT and ZBH, comparing key factors like performance, valuation metrics, dividends, and financial strength.
Company Overview
ABT’s market capitalization of 232.09 billion USD is substantially larger than ZBH’s 18.37 billion USD, indicating a significant difference in their market valuations.
With betas of 0.74 for ABT and 0.72 for ZBH, both stocks show similar sensitivity to overall market movements.
Symbol | ABT | ZBH |
---|---|---|
Company Name | Abbott Laboratories | Zimmer Biomet Holdings, Inc. |
Country | US | US |
Sector | Healthcare | Healthcare |
Industry | Medical - Devices | Medical - Devices |
CEO | Mr. Robert B. Ford | Mr. Ivan Tornos |
Price | 133.4 USD | 92.83 USD |
Market Cap | 232.09 billion USD | 18.37 billion USD |
Beta | 0.74 | 0.72 |
Exchange | NYSE | NYSE |
IPO Date | March 17, 1980 | July 25, 2001 |
ADR | No | No |
Performance Comparison
This chart compares the performance of ABT and ZBH over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Data is adjusted for dividends and splits.
- ABT: $13036.26 (30.36%)
- ZBH: $8715.61 (-12.84%)
Valuation Metrics Comparison
This section compares the market valuation of ABT and ZBH. Key takeaways regarding their valuation, when viewed within their industry context, are presented in the commentary that follows.
- ZBH’s Forward PEG ratio of 2.70 is very high. This signifies that its current stock price is notably elevated compared to its anticipated earnings growth rate, possibly indicating that the market has already factored in, or even exceeded, realistic future performance expectations.
Symbol | ABT | ZBH |
---|---|---|
Price-to-Earnings Ratio (P/E, TTM) | 17.26 | 20.21 |
Forward PEG Ratio (TTM) | 1.73 | 2.70 |
Price-to-Sales Ratio (P/S, TTM) | 5.48 | 2.39 |
Price-to-Book Ratio (P/B, TTM) | 4.78 | 1.49 |
EV-to-EBITDA (TTM) | 21.32 | 10.52 |
EV-to-Sales (TTM) | 5.64 | 3.14 |
Dividend Comparison
ABT’s dividend yield of 1.71% is notably higher than ZBH’s 1.03%, suggesting a stronger emphasis on returning cash to shareholders.
Symbol | ABT | ZBH |
---|---|---|
Dividend Yield (TTM) | 1.71% | 1.03% |
Financial Strength Metrics Comparison
Explore the financial strength details for ABT and ZBH in the table below.
Symbol | ABT | ZBH |
---|---|---|
Current Ratio (TTM) | 1.78 | 2.44 |
Quick Ratio (TTM) | 1.27 | 1.46 |
Debt-to-Equity Ratio (TTM) | 0.27 | 0.58 |
Debt-to-Asset Ratio (TTM) | 0.16 | 0.32 |
Net Debt-to-EBITDA Ratio (TTM) | 0.60 | 2.52 |
Interest Coverage Ratio (TTM) | 15.39 | 5.62 |